A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Percutaneous coronary intervention (PCI) is frequently performed to reduce the symptoms of stable angina. Whether PCI relieves angina more than a placebo procedure in patients who are not receiving antianginal medication remains unknown. METHODS: We conducted a double-blind, randomized, placebo-controlled trial of PCI in patients with stable angina. Patients stopped all antianginal medications and underwent a 2-week symptom assessment phase before randomization. Patients were then randomly assigned in a 1:1 ratio to undergo PCI or a placebo procedure and were followed for 12 weeks. The primary end point was the angina symptom score, which was calculated daily on the basis of the number of angina episodes that occurred on a given day, the number of antianginal medications prescribed on that day, and clinical events, including the occurrence of unblinding owing to unacceptable angina or acute coronary syndrome or death. Scores range from 0 to 79, with higher scores indicating worse health status with respect to angina. RESULTS: A total of 301 patients underwent randomization: 151 to the PCI group and 150 to the placebo group. The mean (±SD) age was 64±9 years, and 79% were men. Ischemia was present in one cardiac territory in 242 patients (80%), in two territories in 52 patients (17%), and in three territories in 7 patients (2%). In the target vessels, the median fractional flow reserve was 0.63 (interquartile range, 0.49 to 0.75), and the median instantaneous wave-free ratio was 0.78 (interquartile range, 0.55 to 0.87). At the 12-week follow-up, the mean angina symptom score was 2.9 in the PCI group and 5.6 in the placebo group (odds ratio, 2.21; 95% confidence interval, 1.41 to 3.47; P<0.001). One patient in the placebo group had unacceptable angina leading to unblinding. Acute coronary syndromes occurred in 4 patients in the PCI group and in 6 patients in the placebo group. CONCLUSIONS: Among patients with stable angina who were receiving little or no antianginal medication and had objective evidence of ischemia, PCI resulted in a lower angina symptom score than a placebo procedure, indicating a better health status with respect to angina. (Funded by the National Institute for Health and Care Research Imperial Biomedical Research Centre and others; ORBITA-2 ClinicalTrials.gov number, NCT03742050.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes
Knuuti, J., Wijns, W., Saraste, A., Capodanno, D., Barbato, E., Funck-Brentano, C., Prescott, E., Storey, R. F., Deaton, C., Cuisset, T., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehz425 · Cited by 7,166
Optimal Medical Therapy with or without PCI for Stable Coronary Disease
Boden, W. E., O'Rourke, R. A., Teo, K. K., Hartigan, P. M., Maron, D. J., Kostuk, W. J., Knudtson, M., Dada, M., Casperson, P., Harris, C. L., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070829 · Cited by 4,699
Virani, S. S., Newby, L. K., Arnold, S. V., Bittner, V., Brewer, L. C., Demeter, S. H., Dixon, D. L., Fearon, W. F., Hess, B., Johnson, H. M., et al. (2023) · Circulation · doi:10.1161/cir.0000000000001168 · Cited by 1,598 · cited 1×
“21,22 The small effect size of PCI on exercise time was surprising in the context of larger effects seen in clinical practice and previous clinical trials.”
Assessment of blinding in clinical trials
Bang, H., Ni, L., & Davis, C. E. (2004) · Controlled Clinical Trials · doi:10.1016/j.cct.2003.10.016 · Cited by 682
Böhm, M., Kario, K., Kandzari, D. E., Mahfoud, F., Weber, M. A., Schmieder, R. E., Tsioufis, K., Pocock, S., Konstantinidis, D., Choi, J. W., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30554-7 · Cited by 606
Self-citationPatel, M. R., Calhoon, J. H., Dehmer, G. J., Grantham, J. A., Maddox, T. M., Maron, D. J., & Smith, P. K. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.10.034 · Cited by 493
Modeling continuous response variables using ordinal regression
Liu, Q., Shepherd, B. E., Li, C., & Harrell, F. E. (2017) · Statistics in Medicine · doi:10.1002/sim.7433 · Cited by 208
Considerations and methods for placebo controls in surgical trials (ASPIRE guidelines)
Beard, D. J., Campbell, M. K., Blazeby, J. M., Carr, A. J., Weijer, C., Cuthbertson, B. H., Buchbinder, R., Pinkney, T., Bishop, F. L., Pugh, J., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(19)33137-x · Cited by 96 · cited 1×
“8,13,27 ORBITA-2 builds on this by demonstrating the ethical basis, feasibility, and necessity of testing a coronary interventional procedure without background therapy that may attenuate its effect.”
Cited by
2024 ESC Guidelines for the management of chronic coronary syndromes
Vrints, C., Andreotti, F., Koskinas, K. C., Rossello, X., Adamo, M., Ainslie, J., Banning, A. P., Budaj, A., Buechel, R. R., Chiariello, G. A., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae177 · Cited by 2,774
Chronological vs Biological Age in Interventional Cardiology
Damluji, A. A., Nanna, M. G., Rymer, J., Kochar, A., Lowenstern, A., Baron, S. J., Narins, C. R., & Alkhouli, M. (2024) · JACC: Cardiovascular Interventions · doi:10.1016/j.jcin.2024.01.284 · Cited by 53
Metadata
- Authors
- Rajkumar, C. A., Foley, M. J., Ahmed-Jushuf, F., Nowbar, A. N., Simader, F. A., Davies, J. R., O’Kane, P. D., Haworth, P., Routledge, H., Kotecha, T., Gamma, R., Clesham, G., Williams, R., Din, J., Nijjer, S. S., Curzen, N., Ruparelia, N., Sinha, M., Dungu, J. N., Ganesananthan, S., Khamis, R., Mughal, L., Kinnaird, T., Petraco, R., Spratt, J. C., Sen, S., Sehmi, J., Collier, D. J., Sohaib, A., Keeble, T. R., Cole, G. D., Howard, J. P., Francis, D. P., Shun-Shin, M. J., & Al-Lamee, R. K.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2023-12-21
- Volume
- 389
- Issue
- 25
- Pages
- 2319-2330
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W4388591774
- Cited by
- 233
- References
- 8
- FWCI
- 55.57
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina. https://app.cochat.ai/papers/10.1056/nejmoa2310610
- The paper
- Rajkumar, C. A., Foley, M. J., Ahmed-Jushuf, F., Nowbar, A. N., Simader, F. A., Davies, J. R., O’Kane, P. D., Haworth, P., Routledge, H., Kotecha, T., Gamma, R., Clesham, G., Williams, R., Din, J., Nijjer, S. S., Curzen, N., Ruparelia, N., Sinha, M., Dungu, J. N., . . . Al-Lamee, R. K. (2023). A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina. New England Journal of Medicine. https://doi.org/10.1056/nejmoa2310610
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.